A New Fad: Microdosing Ozempic

11. December 2024 Health 0
A New Fad: Microdosing Ozempic

(MedPage Today) — A recent New York Times story described a new fad: “microdosing” GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). I was asked to discuss the topic on CBS News recently, which gave…

Powered by WPeMatico